Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2.85	230.03	223.66
Graham Fair Price	-61.81	12.69	33.23
PEG	1818.77	-1.45	0.08
Price/Book	-31.29	8.67	12.62
Price/Cash Flow	-42.52	-220.22	383.14
Prices/Earnings	396.08	123.62	24.92
Price/Sales	-16.55	26.21	31.41
Price/FCF	-42.52	-220.22	383.14
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.60	0.17	0.18
Operating Margin	-32.97	0.05	0.08
ROA	-86.10	0.01	0.07
ROE	0.13	0.02	-86.15
ROIC	0.11	0.01	-88.90
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.90	0.19	369.76
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.17	-0.43	154.40
EPS QOQ	3.29	-0.85	-74.15
FCF QOQ	1.43	-2.23	55.87
Revenue QOQ	0.08	-0.15	97.41
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	59.16	81.96	38.54
Days Sales Outstanding (DSO)	13.22	16.42	24.22
Inventory Turnover	1.52	1.10	-27.82
Debt/Capitalization	0.07	0.08	12.49
Quick Ratio	1.14	1.06	-7.39
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	19.69	20.21	2.62
Cash	9.15	8.55	-6.57
Capex	-0.73	-0.87	-20.18
Free Cash Flow	0.65	-0.80	22.69
Revenue	7.91	6.69	-15.49
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.73	1.72	-0.59
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.21	-0.93	70.87
Naive Interpretation	Member

06 - Financial Health · Weak

Rating